Ovarian Cancer Trial, Recruiting (NCT03954171)

Ovarian Cancer Trial, Recruiting NCT03954171 Sponsor: Institut Claudius Regaud Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03954171 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer) at any stage
Your main surgery to remove the cancer must not have started yet, although pre-surgery chemotherapy is allowed
Your treatment plan must include a chemotherapy type that contains platinum
You must be covered by the French social security system
You must be willing and able to sign a consent form before joining the study

Who may not be able to join:

You have a non-epithelial ovarian tumour or a "borderline" ovarian tumour (a type that is not clearly cancerous)
Your ovarian cancer has come back after previous treatment
Your initial exploratory surgery was not carried out at the Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT-O)
You are currently pregnant or breastfeeding
You have personal, family, location-related, or social circumstances that could make it difficult to attend follow-up appointments or complete study procedures (confirm with trial site)
You are under a legal protection order or have had your freedom restricted by an administrative or legal decision (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 31 15 53 55

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03954171

Sponsor: Institut Claudius Regaud

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 05 31 15 53 55

More information: https://clinicaltrials.gov/study/NCT03954171

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer) at any stage
Your main surgery to remove the cancer must not have started yet, although pre-surgery chemotherapy is allowed
Your treatment plan must include a chemotherapy type that contains platinum
You must be covered by the French social security system
You must be willing and able to sign a consent form before joining the study

Who may not be able to join:

You have a non-epithelial ovarian tumour or a "borderline" ovarian tumour (a type that is not clearly cancerous)
Your ovarian cancer has come back after previous treatment
Your initial exploratory surgery was not carried out at the Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT-O)
You are currently pregnant or breastfeeding
You have personal, family, location-related, or social circumstances that could make it difficult to attend follow-up appointments or complete study procedures (confirm with trial site)
You are under a legal protection order or have had your freedom restricted by an administrative or legal decision (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut Claudius Regaud

Registry

ClinicalTrials.gov

Start date

6 March 2020

Est. completion

1 March 2033

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The rate of patients alive without progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov